ATE553196T1 - Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod - Google Patents

Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod

Info

Publication number
ATE553196T1
ATE553196T1 AT08710243T AT08710243T ATE553196T1 AT E553196 T1 ATE553196 T1 AT E553196T1 AT 08710243 T AT08710243 T AT 08710243T AT 08710243 T AT08710243 T AT 08710243T AT E553196 T1 ATE553196 T1 AT E553196T1
Authority
AT
Austria
Prior art keywords
composition
cell proliferation
modulating
cell death
cell
Prior art date
Application number
AT08710243T
Other languages
English (en)
Inventor
Moshe Oren
Nina Raver-Shapira
Yeal Spector
Efi Marciano
Original Assignee
Rosetta Genomics Ltd
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39608185&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE553196(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rosetta Genomics Ltd, Yeda Res & Dev filed Critical Rosetta Genomics Ltd
Application granted granted Critical
Publication of ATE553196T1 publication Critical patent/ATE553196T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/10—Production naturally occurring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08710243T 2007-02-27 2008-02-26 Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod ATE553196T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90352607P 2007-02-27 2007-02-27
PCT/IL2008/000243 WO2008104974A2 (en) 2007-02-27 2008-02-26 Composition and methods for modulating cell proliferation and cell death

Publications (1)

Publication Number Publication Date
ATE553196T1 true ATE553196T1 (de) 2012-04-15

Family

ID=39608185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08710243T ATE553196T1 (de) 2007-02-27 2008-02-26 Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod

Country Status (6)

Country Link
US (1) US8765702B2 (de)
EP (1) EP2126078B2 (de)
AT (1) ATE553196T1 (de)
AU (1) AU2008220438A1 (de)
CA (1) CA2699418A1 (de)
WO (1) WO2008104974A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103820562B (zh) * 2005-08-01 2015-05-13 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
JP2009507918A (ja) * 2005-09-12 2009-02-26 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション Ｂｃｌ２関連癌の診断及び療法のための組成物及び方法
EP1969147B1 (de) 2006-01-05 2014-07-30 The Ohio State University Research Foundation mikro-RNA-basierte verfahren zur Diagnose von Magenkrebs
US7670840B2 (en) * 2006-01-05 2010-03-02 The Ohio State University Research Foundation Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors
EP2369011A1 (de) 2006-03-20 2011-09-28 The Ohio State University Research Foundation Miko-RNA-Fingerabdrücke während humaner Megakaryozytopoiese
EP2041317A4 (de) 2006-07-13 2009-10-14 Univ Ohio State Res Found Mikro-rna-basierte verfahren und zusammensetzungen zur diagnose und behandlung von erkrankungen in zusammenhang mit darmkrebs
WO2008094545A2 (en) 2007-01-31 2008-08-07 The Ohio State University Research Foundation Mic orna-based methods and compositions for the treatment of acute myeloid leukemia
US9006206B2 (en) * 2007-02-27 2015-04-14 Rosetta Genomics Ltd. Composition and methods for modulating cell proliferation and cell death
JP2010525826A (ja) 2007-05-03 2010-07-29 ロゼッタ インファーマティックス エルエルシー 癌を治療するためのｍｉｒ３４治療剤を含む組成物
CN101918424A (zh) 2007-06-15 2010-12-15 俄亥俄州立大学研究基金会 用于靶向由Drosha介导的微小RNA加工的致癌ALL-1融合蛋白
CN101809169B (zh) * 2007-07-31 2013-07-17 俄亥俄州立大学研究基金会 通过靶向dnmt3a和dnmt3b恢复甲基化的方法
EP2653561B1 (de) 2007-08-03 2016-03-02 The Ohio State University Research Foundation Ultrakonservierte Bereiche zur Codierung von ncRNA
EP3028708A1 (de) * 2007-08-22 2016-06-08 The Ohio State University Research Foundation Verfahren und zusammensetzungen zur induzierung von epha7-deregulierung und erk-phosphorlylierung bei humaner akuter leukämie
EP2775001B1 (de) * 2007-09-06 2016-03-09 The Ohio State University Research Foundation MikroRNA-Signaturen in menschlichem Ovarialkarzinom
EP2212440A4 (de) * 2007-10-11 2011-04-06 Univ Ohio State Res Found Verfahren und zusammensetzungen zur diagnose und behandlung von adenokarzinomen der speiseröhre
CA2703707A1 (en) 2007-10-26 2009-04-30 The Ohio State University Research Foundation Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
CN101918594A (zh) * 2007-11-30 2010-12-15 俄亥俄州立大学研究基金会 肺癌中外周血中的微rna表达特征谱和靶向
CA2716906A1 (en) * 2008-02-28 2009-09-03 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of gastric cancer
JP2012500389A (ja) * 2008-08-12 2012-01-05 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 多発性脊髄腫の診断、予後および治療のためのマイクロｒｎａに基づく組成物および方法
AU2010321555B2 (en) 2009-11-23 2015-10-15 The Ohio State University Materials and methods useful for affecting tumor cell growth, migration and invasion
US8846631B2 (en) 2010-01-14 2014-09-30 Regulus Therapeutics Inc. MicroRNA compositions and methods
EP2600871A2 (de) * 2010-08-04 2013-06-12 The Ohio State University Verfahren zur hinderung einer p53/hdm2- autoregulationsschleife bei der entwicklung multipler myelome mit mir-192, mir-194 und mir-215
ES2606146T3 (es) 2010-11-12 2017-03-22 The Ohio State University Research Foundation Métodos relacionados con microARN-21 y reparación de desapareamiento en cáncer colorrectal
CN103313706A (zh) 2010-11-15 2013-09-18 俄亥俄州立大学研究基金会 控制释放粘膜粘合系统
US8664192B2 (en) 2011-03-07 2014-03-04 The Ohio State University Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer
EP2766500A4 (de) 2011-10-14 2015-10-14 Univ Ohio State Verfahren und materialien in verbindung mit eierstockkrebs
AU2012352265B2 (en) 2011-12-13 2017-02-16 Ohio State Innovation Foundation Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
US8859202B2 (en) 2012-01-20 2014-10-14 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis
WO2014203189A1 (en) 2013-06-18 2014-12-24 Rosetta Genomics Ltd. Nanocarrier system for micrornas and uses thereof
WO2016125163A1 (en) 2015-02-04 2016-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. LIPID ASSEMBLIES AND USES THEREOF AND SOME pH AND ELECTROSTATIC MODULATING LIPIDS TO BE USED IN SAID ASSEMBLIES
US11584932B2 (en) 2016-11-01 2023-02-21 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
CN113041255B (zh) * 2021-04-13 2022-10-11 上海中医药大学 一种新发现miRNA–mRNA调控轴介导肺腺癌NCI-H1299细胞焦亡的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
EP0642589A4 (de) 1992-05-11 1997-05-21 Ribozyme Pharm Inc Methode und reagenz zur inhibierung der viralen replikation.
EP0786522A2 (de) 1992-07-17 1997-07-30 Ribozyme Pharmaceuticals, Inc. Enzymatische RNA-Moleküle zur Behandlung von stenotischen Zuständen
US6395713B1 (en) 1997-07-23 2002-05-28 Ribozyme Pharmaceuticals, Inc. Compositions for the delivery of negatively charged molecules
WO1999004819A1 (en) 1997-07-24 1999-02-04 Inex Pharmaceuticals Corporation Liposomal compositions for the delivery of nucleic acid catalysts
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
ES2702942T3 (es) 2003-04-17 2019-03-06 Alnylam Pharmaceuticals Inc Agentes de ARNi modificados
US7683036B2 (en) 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
CA2554818A1 (en) * 2004-02-09 2005-08-25 Thomas Jefferson University Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
US20050182005A1 (en) 2004-02-13 2005-08-18 Tuschl Thomas H. Anti-microRNA oligonucleotide molecules
EP2290073A3 (de) * 2004-05-28 2011-08-31 Asuragen, Inc. Verfahren und Zusammensetzungen mit MicroRNA
EP2302055B1 (de) 2004-11-12 2014-08-27 Asuragen, Inc. Verfahren und Zusammensetzungen, die miRNAs und miRNAa-inhibitorischen Molekülen verbunden sind
CN103820562B (zh) * 2005-08-01 2015-05-13 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
WO2008088858A2 (en) 2007-01-17 2008-07-24 The Johns Hopkins University Compositions and methods featuring micronas for treating neoplasia

Also Published As

Publication number Publication date
AU2008220438A1 (en) 2008-09-04
US20100104662A1 (en) 2010-04-29
WO2008104974A2 (en) 2008-09-04
EP2126078A2 (de) 2009-12-02
US8765702B2 (en) 2014-07-01
CA2699418A1 (en) 2008-09-04
EP2126078B1 (de) 2012-04-11
EP2126078B2 (de) 2023-01-04
WO2008104974A3 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
ATE553196T1 (de) Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
EP2366794A4 (de) Verfahren zur herstellung von poly-3-hydroxyalkanoat und poly-3-hydroxyalkanoatagglomerat
GEP20217251B (en) Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
ATE553195T1 (de) Zusammensetzungen und verfahren mit rna- interferenz opr3-ähnlichem gen zur kontrolle von nematoden
EP4010004A4 (de) Zusammensetzungen und verfahren zur modulation von genexpression
EP2061482A4 (de) Verfahren zur modulation der expression von epidermalem wachstumsfaktor-rezeptor (egfr) mit mirna
EP2603781A4 (de) System und verfahren zur quantifizierung der farbe und intensität von lichtquellen
EP4031577A4 (de) Verfahren zur züchtung von natürlichen killerzellen gegen bcma-positive tumoren
EP3980068A4 (de) Zellkulturverfahren und zusammensetzungen zur produktion von antikörpern
EP4048792A4 (de) Zusammensetzungen und verfahren zur editierung des cdkl5-gens
ATE480615T1 (de) Verfahren zur proliferation von stammzellen
EA200970407A1 (ru) Ингибиторы киназ mapk/erk
EP2266633A4 (de) Gasdekompositionsvorrichtung und verfahren zur dekomposition von gas
EP3511410A4 (de) Medium zur kultivierung von stammzellen, verfahren zur kultivierung von stammzellen, stammzellenwachstumsförderer und zusammensetzung und verfahren zur herstellung davon
EP2133158A4 (de) Verfahren zur entgiftung von asbest
EP4326878A4 (de) Zusammensetzungen und verfahren zur modulierung von sos-genexpressionen
EP4103691C0 (de) Zellkultursubstrate, verfahren und verwendungen davon
DE502006004410D1 (de) Verfahren zur herstellung von pfropfpolymerisaten
ATE540755T1 (de) Verwendung von katalysatorzusammensetzungen und verfahren zur oxychlorierung
EP2118305A4 (de) Verfahren und kits zur dna-amplifikation
CA2725963A1 (en) Screening methods for heat-shock response modulators
EP1888106A4 (de) Zusammensetzungen und verfahren zur behandlung von ephrinsignalisierung mit cupredoxinen
EP4415728A4 (de) Zusammensetzungen und verfahren zur herstellung von t-zellen